| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 132539-06-1 | 奧氮平; 2-甲基-4-(4-甲基-1-哌嗪基)-10H-噻吩并[2,3-b][1,5]苯并二氮雜 | Olanzapine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; Lanzac; Zyprexa |  | C17H20N4S | 詳情 | 供應(yīng)商 |
| 161696-76-0 | 2-甲基-4-(1-哌嗪基)-10H-噻吩并[2,3-b][1,5]苯并二氮雜卓 | 2-Methyl-4-(1-piperazinyl)-10H-thienol[2,3-b][1,5]benzodiazepine; 4'-Desmethylolanzapine; Desmethylolanzapine; LY 170055; N-Demethylolanzapine |  | C16H18N4S | 詳情 | 供應(yīng)商 |
| 929095-18-1 | 5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺; 5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺; GSK461364; 5-[6-[(4-甲基-1-哌嗪基)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩甲酰胺 | 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide; 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide; GSK-461364; (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide; GSK-461364A; GSK461364(GSK-461364) |  | C27H28F3N5O2S | 詳情 | 供應(yīng)商 |
| 913614-18-3 | 4-哌嗪基苯并噻吩鹽酸鹽 | Piperazine, 1-benzo[b]thien-4-yl-, hydrochloride | 無(wú) | 詳情 | 供應(yīng)商 |